AZNIX
Price
$11.73
Change
-$0.07 (-0.59%)
Updated
Jun 13 closing price
Net Assets
4.6B
RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

AZNIX vs RLBGX

Header iconAZNIX vs RLBGX Comparison
Open Charts AZNIX vs RLBGXBanner chart's image
Virtus Income & Growth Inst
Price$11.73
Change-$0.07 (-0.59%)
VolumeN/A
Net Assets4.6B
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
AZNIX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AZNIX vs. RLBGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNIX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. AZNIX (4.6B). RLBGX (2.23) and AZNIX (2.16) have matching dividends . AZNIX was incepted earlier than RLBGX: AZNIX (18 years) vs RLBGX (16 years). AZNIX (0.91) is less costly to investors than RLBGX (0.25). AZNIX is a more actively managed with annual turnover of: 61.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than AZNIX: RLBGX (250) vs AZNIX (1000000). RLBGX annual gain was more profitable for investors over the last year : 5.63 vs. AZNIX (2.80). RLBGX return over 5 years is better than : 40.35 vs. AZNIX (15.82).
AZNIXRLBGXAZNIX / RLBGX
Total Expense Ratio0.900.25360%
Annual Report Gross Expense Ratio0.910.25364%
Fund Existence18 years16 years-
Gain YTD0.0104.5920%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.6B244B2%
Annual Yield % from dividends2.162.2397%
Returns for 1 year2.805.6350%
Returns for 3 years16.8833.7850%
Returns for 5 years15.8240.3539%
Returns for 10 years16.5860.8727%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp